AEAkram Eidi

Akram Eidi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akram Eidi has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigation of the effect of cerebrospinal fluid from brain-injured rats on the growth and differentiation of neural progenitor cells on neural progenitor cells in vitro

    by Reyhan Sadeghi, Akram Eidi, Koroush Shahpasand, Ehsan Ehsani

    Introduction: Traumatic brain injury (TBI) encompasses a wide range of brain lesions caused by a blow to or severe impact on the head. Traumatic brain injuries are divided into four categories based on their symptoms and consequences: mild, moderate, severe, and very severe. Studies in animal models have shown that TBI leads to neurodegeneration, progressive brain atrophy, and changes in cerebrospinal fluid (CSF) composition. The aim of this study was to investigate the effect of CSF isolated from TBI victims on neurodegeneration and the differentiation of neural progenitor cells (NPCs). Methods: To achieve this goal, the expression of genes involved in NPC differentiation and the induction of tauopathy in these cells were examined. First, an animal model of craniocerebral trauma was created in rats, and CSF was collected. The collected CSF was then added to the NPC culture medium to study its effect on cell behavior. The cells were divided into three groups: NPC, NPC + EGF/bFGF, and NPC + EGF/bFGF + CSF. After seven days, the expression of Nestin, Pax6, Map2, and Tubb3 genes was measured by real-time PCR, and TAU expression was evaluated by immunocytochemistry. Results: A significant decrease in Nestin and Pax6 expression (P = 0.0001 for both) was observed in the experimental group. Map2 and Tubb3 expression increased (P = 0.0001 and P = 0.0002, respectively), indicating NPC differentiation. In addition, immunocytochemistry revealed elevated TAU protein levels (P = 0.05), consistent with tauopathy induction. Conclusion: We conclude that CSF obtained from TBI rats promotes neuronal differentiation but simultaneously exerts neurotoxic effects through tauopathy induction.

  • Open Access

    Neuroprotective Effects of Rosa damascena Essential Oil Against Ethanol-Induced Toxicity in Neural Progenitor Cells

    by Fatemeh Hakimi, Akram Eidi, Ehsan Ehsani, Mahdi Ayyari, Koorosh Shahpasand

    Background: Neural progenitor cells (NPCs) in specific regions of the adult brain hold promise for treating central nervous system (CNS) disorders and degenerative diseases, such as Parkinson's and Alzheimer's. Rosa damascena, enriched with flavonoids, offers restorative, inhibitory, and protective advantages against nerve damage. Objectives: This study investigates the neuroprotective effects of R. damascena essential oil (ESO) on NPCs exposed to ethanol (ETH)-induced toxicity. Methods: The study involved two phases: The NPCs were isolated from the brains of young Wistar rats and cultured following standard protocols. Differentiation into mature neural cells (NCs) was induced by withdrawing supportive factors. MTT assays were used to determine effective ETH and ESO doses, followed by assessments of their impact on NPCs and NCs. Gene expression analysis of neuroepithelial stem cell protein (Nestin), Sex determining region Y-box 2 (Sox2), and Paired Box 6 (Pax6) was conducted using real-time PCR during the NPC phase, while class III β-tubulin (Tuj1) and microtubule associated protein 2 (Map2) were evaluated during the NC stage. TAU protein expression was analyzed via immunocytochemistry (ICC). Results: The ETH exposure significantly reduced cell viability in a dose- and time-dependent manner (24, 48, 72 hours), while treatment with 200 µM ESO significantly improved survival in NPCs and NCs (P < 0.001). Additionally, ESO reduced TAU protein expression in NCs exposed to ETH. The NPCs treated with ETH + ESO showed increased expression of Nestin, Sox2, and Pax6 compared to the ETH-only group (P < 0.01). Similarly, Tuj1 and Map2 expression levels were significantly higher in the ETH + ESO group compared to ETH-treated NCs (P < 0.01). Conclusions: The ESO demonstrates significant neuroprotective properties, mitigating ETH-induced toxicity in NPCs and NCs. These findings highlight its potential as a therapeutic agent for reducing neurodegenerative damage and supporting nervous system function.


  • Open Access

    Peganum harmala Extracts as a Hypoglycemic and Hepatoprotective Agent in Diabetes-Induced Liver Damage

    by Kobra Jafari, Shahrbanoo Oryan, Ramesh Ahmadi, Akram Eidi

    Background: Liver disorders associated with type II diabetes result in cellular death, highlighting the importance of exploring protective mechanisms such as apoptosis to mitigate tissue damage. Antioxidant agents are promising options to address this issue, and plant secondary metabolites, such as the alkaloids of Peganum harmala, are considered among the most effective factors for treating liver disorders. Objectives: This study aimed to examine apoptosis, along with biochemical and histopathological parameters, in the liver of diabetic Wistar rats using methanolic extracts of P. harmala from seeds and leaves. Methods: Peganum harmala was collected from Zahedan. Phytochemical analysis of the leaf and seed extracts was conducted via high-performance liquid chromatography (HPLC) and DPPH tests. Sixty-four male Wistar rats (250 - 300 g) were organized into eight groups of eight individuals. Diabetes was induced by a 70 mg/kg streptozotocin (STZ) injection. The treatment groups were administered 150 mg/kg of leaf or seed extracts, or 6.5 mg/kg of harmine, a P. harmala alkaloid, daily for four weeks. Samples were then collected from anesthetized rats for biochemical, histopathological, and flow cytometry analyses. Results: The results indicated that methanolic extracts of P. harmala seed reduced plasma cholesterol and triglyceride levels in both healthy and diabetic groups. Biochemical tests also demonstrated that the seed extracts and harmine significantly reduced the plasma levels of liver enzymes. The leaf extracts and harmine significantly reduced apoptosis among diabetic groups, while seed extracts induced more apoptosis. The group treated with the seed extracts showed significant levels of healing and recovery in the liver tissue in histopathological evaluations. Conclusions: The significant antioxidant characteristics of the seed extract of P. harmala suggest its potential as a hypoglycemic medicine to moderate complications associated with diabetes.


  • Effect of Nano Selenium on Cadmium Chloride‐Induced Infertility in Male Wistar Rats

    by Shahrbano Taromsari, Akram Eidi, Pejman Mortazavi, Mehrdad Modaresi

    Selenium (Se) is an essential trace element with well‐documented health benefits, including antioxidative, anti‐inflammatory, antiapoptotic, and anticarcinogenic properties. Selenium nanoparticles (nano‐Se) represent an advanced Se delivery system characterized by superior bioavailability and a reduced risk of Se‐related toxicity. This study investigates the protective efficacy of nano‐Se against cadmium chloride (CdCl 2 )‐induced infertility in adult male Wistar rats. The experimental design involved random allocation of the rats into nine groups: a healthy control group, a vehicle control group, three groups receiving nano‐Se alone at 0.05, 0.1, and 0.2 mg/kg b.w./day, a group exposed to CdCl 2 to induce infertility, and three CdCl 2 ‐exposed groups treated with nano‐Se. After 30 days of treatment, the animals were euthanized for biochemical and histopathological assessments. The findings revealed that nano‐Se administration ameliorated the detrimental effects of treatment CdCl 2 on serum testosterone levels. Additionally, nano‐Se significantly reduced malondialdehyde levels and enhanced the activity of antioxidant enzymes in testicular homogenates. Histological analyses further demonstrated that nano‐Se preserved the structural integrity of testicular tissue in the CdCl 2 ‐induced fertility model. Nano‐Se modulated apoptotic pathways, as evidenced by the suppression of Bax expression and upregulation of Bcl 2 expression in testicular tissue. Furthermore, nano‐Se mitigated the overexpression of aquaporin‐9 in CdCl 2 ‐exposed rats. Collectively, these results provide robust biochemical, histological, and biochemical evidence supporting the potential therapeutic utility of nano‐Se in mitigating testicular dysfunction.


  • Carvacrol attenuates varicocele-induced infertility in rats

    by Elham Ghahreman, Akram Eidi, Pejman Mortazavi, Ahmad Asghari, Masoumeh Asle-Rousta


  • Protective effect of nano magnesium oxide on renal ischemia/reperfusion injury in male Wistar rats

    by Marzieh Minaei, Akram Eidi, Pejman Mortazavi, Ahmad Asghari

    Ischemia/reperfusion (I/R) injury is a main issue in renal transplantation, and antioxidants attenuate I/R injury in different tissues. We investigated the protective effects of nano magnesium oxide (nano-MgO) on renal I/R injury in rats. Induction of I/R injury was performed through clamping the left renal pedicle for 20 minutes. Animals were administrated with nano-MgO (1.25, 2.5 and 5 mg/kg) for 30 days by gavage, and were sacrificed for biochemical and histopathological studies. Our findings show that nano-MgO administration (2.5 and 5 mg/kg) in rats with renal I/R injury significantly attenuated serum creatinine and urea levels (p<0.001), decreased malondialdehyde (MDA) levels and elevated antioxidant enzyme activities in renal homogenates (p<0.001), as evidenced by histopathological assessment, and caused a significant reduction in EGF immunoreactivity and EGFR expression in renal tissues (p<0.001). In conclusion, nano-MgO administration preserves renal function and prevents tissue damage after I/R injury in rats.


  • Open Access

    Enhancing Drug Delivery of Glatiramer Acetate Through In Vitro Development of Controlled-Release Nanoliposomes: Investigating Drug Release Kinetics and Cytotoxic Effects

    by Danial Farahmand, Mohammad Reza Mehrabi, Akram Eidi

    Background: Multiple sclerosis (MS) damages the myelin sheath covering nerve fibers. This condition affects 400,000 individuals in the United States and 2.5 million people globally, with a higher rate of diagnosis in women aged 20 - 40, with a ratio of 2:1. Liposomes facilitate drug dispersion, making them valuable in biomedicine. They enhance the stability of therapeutic medications, improve cellular and tissue absorption, and increase chemical bioactivity at specific locations. This technique delivers encapsulated compounds with high precision while minimizing negative consequences observed in laboratory settings. Objectives: This study aims to develop an optimal nanoliposome formulation using glatiramer acetate (GA) as the active pharmaceutical ingredient by examining drug release and associated adverse effects to achieve the most effective nanoliposomal system. Methods: The thin layer hydration method was used to prepare nanoliposomes. A comprehensive array of analytical techniques, including FE-SEM, FTIR, XRD, HPLC, and DLS, were employed to examine the physicochemical characteristics of the product. Additionally, the biosafety of the nanoliposomes was assessed using the MTT assay on the 1321N1 human astrocytoma cell line. The release profile of GA from the carrier was studied using the dialysis diffusion method, and the stability of the nanoliposomes was also inspected. Results: The size, Polydispersity Index (PDI), and zeta potential of the nanoliposomes were 91.2 ± 1.3 nm, 0.34 ± 0.03, and -27.3 ± 1.2 mV, respectively. The drug entrapment efficiency (DEE%) in nanoliposomes was approximately 70.2 ± 1.7%. The results from XRD and FTIR revealed no chemical interaction between the drug and carrier, and the nanoliposomes were safe for the cultured cell line. The nanoliposomes were stable under storage conditions and exhibited a sustained release profile. Conclusions: Nanoliposomes, as drug carriers, are known to be a potent drug delivery system due to their numerous advantages. Based on the results, GA-nanoliposomes show promise as a strategy for treating MS patients, pending further in vivo experiments and clinical trials.